These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27080620)

  • 1. Acute Kidney Injury in Elderly Patients With Chronic Kidney Disease: Do Angiotensin-Converting Enzyme Inhibitors Carry a Risk?
    Chaumont M; Pourcelet A; van Nuffelen M; Racapé J; Leeman M; Hougardy JM
    J Clin Hypertens (Greenwich); 2016 Jun; 18(6):514-21. PubMed ID: 27080620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
    Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H
    Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Osteoporotic Fractures With Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors in Hypertensive Community-Dwelling Elderly.
    Butt DA; Mamdani M; Gomes T; Lix L; Lu H; Tu K;
    J Bone Miner Res; 2014 Nov; 29(11):2483-8. PubMed ID: 24806397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of acute kidney injury in patients prescribed angiotensin-converting enzyme inhibitors over the first two years of life.
    Hirano D; Miwa S; Kakegawa D; Umeda C; Takemasa Y; Tokunaga A; Yuhei K; Ito A
    Pediatr Nephrol; 2021 Jul; 36(7):1907-1914. PubMed ID: 33462699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors.
    Terano C; Ishikura K; Miura M; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Ando T; Honda M
    Eur J Pediatr; 2016 May; 175(5):631-7. PubMed ID: 26687571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
    Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
    Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system blocker use and the risk of acute kidney injury after colorectal cancer surgery: a population-based cohort study.
    Slagelse C; Gammelager H; Iversen LH; Liu KD; Sørensen HTT; Christiansen CF
    BMJ Open; 2019 Nov; 9(11):e032964. PubMed ID: 31753901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease.
    Spatz C; Saadulla L; Lapsiwala A; Parhizgar A; Ghahramani N
    Iran J Kidney Dis; 2012 Nov; 6(6):432-6. PubMed ID: 23146980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can ACE inhibitors and angiotensin receptor blockers be detrimental in CKD patients?
    Onuigbo MA
    Nephron Clin Pract; 2011; 118(4):c407-19. PubMed ID: 21389735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
    Benedetto U; Sciarretta S; Roscitano A; Fiorani B; Refice S; Angeloni E; Sinatra R
    Ann Thorac Surg; 2008 Oct; 86(4):1160-5. PubMed ID: 18805152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prior to septic shock and acute kidney injury.
    Suberviola B; Rodrigo E; González-Castro A; Serrano M; Heras M; Castellanos-Ortega Á
    Med Intensiva; 2017; 41(1):21-27. PubMed ID: 28341094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of Acute Kidney Injury on 309 Hypertensive Inpatients with ACEI/ARB - Diuretic Treatment.
    Chen Q; Zhu S; Liao J; He W
    J Natl Med Assoc; 2018 Jun; 110(3):287-296. PubMed ID: 29778133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute kidney injury post-major orthopaedic surgery: A single-Centre case-control study.
    Ying T; Chan S; Lane S; Somerville C
    Nephrology (Carlton); 2018 Feb; 23(2):126-132. PubMed ID: 27706879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
    Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
    Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury.
    Gayat E; Hollinger A; Cariou A; Deye N; Vieillard-Baron A; Jaber S; Chousterman BG; Lu Q; Laterre PF; Monnet X; Darmon M; Leone M; Guidet B; Sonneville R; Lefrant JY; Fournier MC; Resche-Rigon M; Mebazaa A; Legrand M;
    Intensive Care Med; 2018 May; 44(5):598-605. PubMed ID: 29766216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of renin-angiotensin-aldosterone system-blocking agents on the risk of contrast-induced acute kidney injury: a prospective study and meta-analysis.
    Peng F; Su J; Lin J; Niu W
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):262-8. PubMed ID: 25502308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
    Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
    J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.